Stock Taper
SCREENER COMPARE ANY 2 STOCKS
YDES
YD BIO LIMITED ORDINARY SHARES
NASDAQ
$4.80
▲ UP 24.03% (0.93)

KEY STATISTICS

Market Cap$339.99 M
52w High$25.00
52w Low$1.70
Dividend Yield—
Frequency—
P/E-40.00
Volume217.67K
Shares Out.70.83M

COMPANY

LEADERSHIP

Ethan Shen
CHIEF EXECUTIVE
Ethan Shen

ABOUT

SECTOR
Healthcare
WENT PUBLIC
August 29, 2025
METHOD OF GOING PUBLIC
N/A
FULL TIME EMPLOYEES
15

PRICE

$4.80 ▲ UP 24.03% (+$0.93)
$3.20$3.60$4.009:30 AM10:32 AM11:34 AM12:36 PM1:39 PM2:41 PM3:43 PM4.80

About YD Bio Limited Ordinary Shares

https://www.ydesgroup.com ↗

Breeze Holdings Acquisition Corp., based in Taipei, Taiwan, is a clinical-stage biopharmaceutical company developing exosome-based diagnostics and therapeutics to address unmet medical needs in cancer prevention and treatment.

INDUSTRY

Biotechnology

A PRODUCT YD BIO LIMITED ORDINARY SHARES IS KNOWN FOR

Exovisse Contact Lenses and Artificial Tears
Exovisse Contact Lenses and Artificial Tears

YD Bio's new eye care product line, including FDA-cleared Exovisse Contact Lenses and OTC-compliant Artificial Tears, marks the company's first U.S. market entry into regulated eye health solutions.

COMPETITORS

COMPETITOR
ALC COMPARE
BLCO COMPARE
COO COMPARE
JNJ COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
1
LISTED HERE
1
RANKED BY POSITION SIZE
ONEQ
0.00% · 22.9K

RATINGS SNAPSHOT

Overall rating: D+

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score1

INSIDER TRADES

★
DIRECTOR
Lu Shao-Ta
Purchase · 5.7K shares
2026-06-30
★
DIRECTOR
Lu Shao-Ta
Purchase · 5.7K shares
2026-06-30
★
DIRECTOR
Chang Kochi
Purchase · 5.7K shares
2026-06-30
★
DIRECTOR
Chang Kochi
Purchase · 5.7K shares
2026-06-30

SECTORS PEERS

PEERPRICE
VIR$10.83COMPARE
TYRA$24.94COMPARE
GLUE$13.38COMPARE
MRVI$7.68COMPARE
BTX$8.96COMPARE
GERN$1.51COMPARE
TBPH$17.05COMPARE
PRME$3.61COMPARE